The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Abstract
The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is an inverse relationship between serum HDL levels and the risk of coronary heart disease49,50.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [49]
In the citing paper
“For many decades, a low level of HDL-C has been viewed as a robust and independent CVD risk factor1-4.”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [1]
Citations
Cites
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456
Research works printed but not linked: 13
- Miller, 1973, J. Lab. clin. Med., 82, 876
- Goodman, 1973, J. Lipid Res., 52, 2646
- Insull, 1968, J. Lab. clin. Med., 72, 885
- Schreibman, 1973, Clin. Res., 21, 638
- P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
- Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
- Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
- N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
- Kannel, 1962, Geriatrics, 17, 675
- Murphy, 1962, J. Lab. clin. Med., 60, 86
- Kudchodkar, 1972, Clin. Res., 20, 944
- Jones, 1970, J. Lab. clin. Med., 75, 953
- Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123
Cited by
Sorted by citations
Items 501–600 of 1,001
Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L., Chiu, D., Rodríguez, B. L., Curb, J. D., & Sharp, D. S. (1995) · Circulation · doi:10.1161/01.cir.92.6.1430 · Cited by 78
Lipoprotein fractionation by a precipitation method. a simple quantitative procedure
Ononogbu, I. C., & Lewis, B. (1976) · Clinica Chimica Acta · doi:10.1016/0009-8981(76)90090-5 · Cited by 78
Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics
Lisch, H. ‐., & Sailer, S. (1981) · Diabetologia · doi:10.1007/bf00262013 · Cited by 78
Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI
Kocher, O. N., & Krieger, M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832aee82 · Cited by 78
GPR109A and Vascular Inflammation
Chai, J. T., Digby, J. E., & Choudhury, R. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0325-9 · Cited by 78
Bhatt, J., Gopa, B., & Hemavathi, K. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.93857 · Cited by 78
Changes in high density lipoprotein subfractions and other lipoproteins induced by exercise
Nye, E. R., Carlson, K., Kirstein, P., & Rössner, S. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90439-3 · Cited by 77
Beitz, J., & FÖRSTER, W. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90126-5 · Cited by 77
Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells.
Spector, A. A., Scanu, A. M., Kaduce, T. L., Figard, P. H., Fless, G. M., & Czervionke, R. L. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34371-6 · Cited by 77
Reilly, S. L., Ferrell, R. E., Kottke, B. A., & Sing, C. F. (1992) · PubMed · Cited by 77
Diet and plasma lipids—a reappraisal
Truswell, A. S. (1978) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.6.977 · Cited by 77
THE EFFECT OF METOPROLOL AND ATENOLOL ON PLASMA HIGH DENSITY LIPOPROTEIN LEVELS IN MAN
England, J. D. F., Simons, L. A., Gibson, J. C., & Carlton, M. (1980) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1980.tb00078.x · Cited by 77
Cholesterol metabolism in copper deficient rats
Allen, K. G. D., & Klevay, L. M. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90620-3 · Cited by 77
Pig plasma phospholipid transfer protein facilitates HDL interconversion.
Pussinen, P. J., Jauhianinen, M., Metso, J., Tyynelä, J., & Ehnholm, C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39855-2 · Cited by 77
Metabolic Syndrome in Men with Klinefelter's Syndrome
Ishikawa, T., Yamaguchi, K., Kondo, Y., Takenaka, A., & Fujisawa, M. (2008) · Urology · doi:10.1016/j.urology.2008.01.051 · Cited by 76
Walldius, G., & Jungner, I. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281bd8849 · Cited by 76
Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits.
Sharma, I., Gusain, D., & Dixit, V. P. (1991) · PubMed · Cited by 76
Sparks, D. L., Davidson, W. S., Lund‐Katz, S., & Phillips, M. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49456-8 · Cited by 76
Marzal-Casacuberta, À., Blanco‐Vaca, F., Ishida, B. Y., Julve, J., Shen, J. J., Calvet-Márquez, S., González‐Sastre, F., & Chan, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6720 · Cited by 76
Masarei, J. R. L., Rouse, I. L., Lynch, W. J., Robertson, K., Vandongen, R., & Beilin, L. J. (1984) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/40.3.468 · Cited by 76
The Effect of Exercise on Lipid Metabolism in Men and Women
Goldberg, L., & Elliot, D. L. (1987) · Sports Medicine · doi:10.2165/00007256-198704050-00001 · Cited by 76
KEKKI, M. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90102-1 · Cited by 76
Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds
Glueck, C. J., Gartside, P. S., Steiner, P. M., Miller, M., Todhunter, T., ten Haaf, J., Pucke, M., Terrana, M., Fallat, R. W., & Kashyap, M. L. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90159-9 · Cited by 76
Gartside, P. S., Khoury, P. R., & Glueck, C. J. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90649-5 · Cited by 76
Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoids
Willis, A. L., Smith, D. L., & Vigo, C. (1986) · Progress in Lipid Research · doi:10.1016/0163-7827(86)90132-3 · Cited by 76
Connelly, M. A., de la Llera-Moya, M., Monzo, P., Yancey, P. G., Drazul‐Schrader, D., Stoudt, G. W., Fournier, N., Klein, S. M., Rothblat, G. H., & Williams, D. L. (2001) · Biochemistry · doi:10.1021/bi002825r · Cited by 75
Lindstedt, L., Lee, M., Castro, G. R., Fruchart, J., & Kovanen, P. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118658 · Cited by 75
Romm, P. A., Green, C. E., Reagan, K., & Rackley, C. E. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90007-8 · Cited by 75
Desrumaux, C. M., Mak, P. A., Boisvert, W. A., Masson, D., Stupack, D., Jauhiainen, M., Ehnholm, C., & Curtiss, L. K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200281-jlr200 · Cited by 75
Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism
Tu, A.-Y., & Albers, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1851 · Cited by 75
Cho, K.-H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.7.393 · Cited by 74
Liu, M., & Williams, K. J. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835057e9 · Cited by 74
Proteinases and myocardial extracellular matrix turnover
Tyagi, S. C. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006850903242 · Cited by 74
Carr, M. C., Hokanson, J. E., Deeb, S. S., Purnell, J. Q., Mitchell, E. S., & Brunzell, J. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2701 · Cited by 74
Differential tissue-specific expression of human apoA-I and apoA-II
Eggerman, T., Hoeg, J. M., Meng, M., Tombragel, A., Bojanovski, D., & Brewer, H. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42034-6 · Cited by 74
Farrell, P. A., & Barboriak, J. J. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90008-8 · Cited by 74
Lipoprotein Lipase: Its physiological and clinical significance
Hamosh, M., & Hamosh, P. (1983) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(83)90006-7 · Cited by 74
Schaefer, E. J., Anderson, D. W., Zech, L. A., Lindgren, F. T., Bronzert, T. B., Rubalcaba, E. A., & Brewer, H. B. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35365-7 · Cited by 74
Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis
Tanaka, S., Genève, C., Zappella, N., Yong-Sang, J., Planesse, C., Louedec, L., Viranaïcken, W., Bringart, M., Montravers, P., Denamur, É., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003155 · Cited by 75
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
Tomás, M., Latorre, G. N., Sentı́, M., & Marrugat, J. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60630-0 · Cited by 73
Duchateau, P. N., Movsesyan, I., Yamashita, S., Sakai, N., Hirano, K., Schoenhaus, S. A., O'Connor-Kearns, P. M., Spencer, S. J., Jaffe, R. B., Redberg, R. F., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33430-1 · Cited by 73
High density lipoproteins and the growth of vascular endothelial cells in serum-free medium
Tauber, J.-P., Cheng, J., Massoglia, S. L., & Gospodarowicz, D. (1981) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02633513 · Cited by 73
The benefits and risks of hormone replacement therapy: An epidemiologic overview
Harlap, S. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91399-u · Cited by 73
Familial aggregation and early expression of hyperapobetalipoproteinemia
Sniderman, A. D., Teng, B., Genest, J. J., Cianflone, K., Wacholder, S., & Kwiterovich, P. O. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90363-7 · Cited by 73
Zavaroni, I., Dall’Aglio, E., Bonora, E., Alip, O., Passeri, M., & Reaven, G. M. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90887-4 · Cited by 73
Avogaro, P., Cazzolato, G., Bittolo-Bon, G., & Belussi, F. (1982) · La Ricerca in Clinica e in Laboratorio · doi:10.1007/bf02909312 · Cited by 73
Xue, J., Yuan, Z., Wu, Y., Liu, Y., Zhao, Y., Zhang, W., Tian, Y., Liu, W., Liu, Y., & Kishimoto, C. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp388 · Cited by 72
The health benefits of moderate alcohol consumption: A review of the literature
Baum-Baicker, C. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90001-8 · Cited by 72
Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis
Tape, C., & Kisilevsky, R. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90030-2 · Cited by 72
PASSCLAIM - Diet-related cardiovascular disease
Mensink, R. P., Aro, A., Hond, E. D., German, J. B., Griffin, B. A., ten Meer, H.-U., Mutanen, M. L., Pannemans, D. L. E., & Stahl, W. (2003) · European Journal of Nutrition · doi:10.1007/s00394-003-1102-2 · Cited by 72
Um, K., Hämäläinen, L., Taskinen, M., Kettunen, K., & KONTULA, K. K. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40754-0 · Cited by 72
Temporal and Compositional Dietary Restrictions Modulate Age-Related Changes in Serum Lipids
Masoro, E. J., Compton, C., Yu, B. P., & Bertrand, H. A. (1983) · Journal of Nutrition · doi:10.1093/jn/113.4.880 · Cited by 72
Effect of oral 13-cis-retinoic acid on serum lipids
LYONS, F., Laker, M. F., Marsden, J. R., MANUEL, R., & Shuster, S. (1982) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1982.tb00411.x · Cited by 72
Farrell, P. A., Maksud, M. G., Pollock, M. L., Foster, C., Anholm, J. D., Hare, J., & Leon, A. S. (1982) · European Journal of Applied Physiology · doi:10.1007/bf00421167 · Cited by 72
Schaefer, E. J., Kay, L. L., Zech, L. A., & Brewer, H. B. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110705 · Cited by 72
Groot, P. H. E., Scheek, L. M., Havekes, L. M., van Noort, W. L., & Hooft, F. M. V. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38040-8 · Cited by 72
Gemfibrozil Therapy in Primary Hypertriglyceridemia Associated With Coronary Heart Disease
Vega, G. L. (1985) · JAMA · doi:10.1001/jama.253.16.2398 · Cited by 72
Cheung, P. C. K. (1998) · Journal of Nutrition · doi:10.1093/jn/128.9.1512 · Cited by 71
Peloso, G. M., Demissie, S., Collins, D. E., Mirel, D. B., Gabriel, S., Cupples, L. A., Robins, S. J., Schaefer, E. J., & Brousseau, M. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p008268 · Cited by 71
Kodaman, N. M., Aldrich, M. C., Sobota, R. S., Asselbergs, F. W., Poku, K. A., Brown, N. J., Moore, J. H., & Williams, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162753 · Cited by 71
Serum lipids in hyper- and hypothyroidism before and after treatment
Friis, T., & Pedersen, L. R. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90447-5 · Cited by 71
Childs, M. T., Bowlin, J. A., Ogilvie, J. T., Hazzard, W. R., & Albers, J. J. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90119-2 · Cited by 71
Berglund, L., Oliver, E. H., Fontanez, N., Holleran, S., Matthews, K. A., Roheim, P. S., Ginsberg, H. N., Ramakrishnan, R., & LeFevre, M. L. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.992 · Cited by 71
High density lipoprotein catabolism before and after partial hepatectomy
van Tol, A., van Gent, T., Hooft, F. M. V., & Vlaspolder, F. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90172-7 · Cited by 71
SERUM LIPOPROTEINS AND SUSCEPTIBILITY OF MEN OF INDIAN DESCENT TO CORONARY HEART DISEASE
Miller, G. J., Alexis, S. D., Beckles, G. L., BYAM, N. T. A., & Price, S. G. L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91041-8 · Cited by 70
Self-citationLevels of Lipids, Lipoproteins, and Apolipoproteins in a Defined Population
Kottke, B. A., Moll, P. P., Michels, V. V., & Weidman, W. H. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62470-7 · Cited by 70
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol
D, A.-B., S M, H., E, H., K H, L., J J, A., & W R, H. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.3.360 · Cited by 85
Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy
Aviram, M., Luboshitzky, R., & Brook, J. G. (1982) · Clinical Biochemistry · doi:10.1016/s0009-9120(82)90529-x · Cited by 69
Turner, S., Voogt, J. N., Davidson, M. H., Glass, A., Killion, S., Decaris, J., Mohammed, H., Minehira, K., Boban, D., Murphy, E. J., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001826 · Cited by 73
Maruyama, T., Sakai, N., Ishigami, M., Hirano, K., Arai, T., Okada, S., Okuda, E., Ohya, A., Nakajima, N., Kadowaki, K., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00327-1 · Cited by 69
Koo, S. I., & Williams, D. A. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.11.2376 · Cited by 69
Determination of high density lipoprotein-cholesterol in stored human plasma.
Bachorik, P. S., WALKER, R. E., Brownell, K. D., Stunkard, A. J., & Kwiterovich, P. O. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42231-x · Cited by 69
TREATMENT OF POST‐MENOPAUSAL HYPERCHOLEROLAEMIA WITH ESTRADIOL
Tikkanen, M. J., Kuusi, T., Vartiainen, E., & Nikkilä, E. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157234 · Cited by 69
Paisey, R., Elkeles, R. S., Hambley, J., & Magill, P. (1978) · Diabetologia · doi:10.1007/bf00422249 · Cited by 69
Khazaál, M. S. (2013) · Karbala Journal of Medicine · Cited by 68
Role of lipids and lipoprotein fractions in atherogenesis: The framingham study
Kannel, W. B., Gordon, T., & Castelli, W. P. (1981) · Progress in Lipid Research · doi:10.1016/0163-7827(81)90067-9 · Cited by 68
Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol
Moffatt, R. J. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90194-3 · Cited by 68
REDUCED HIGH-DENSITY LIPOPROTEIN IN WOMEN AGED 40-41 USING ORAL CONTRACEPTIVES
Arntzenius, A. C., van Gent, C. M., van der Voort, H. A., Stegerhoek, C. I., & Styblo, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92461-3 · Cited by 68
Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins
Witztum, J. L., Schonfeld, G., Weidman, S. W., Giese, W. E., & Dillingham, M. A. (1979) · Metabolism · doi:10.1016/0026-0495(79)90067-2 · Cited by 68
Kjeldsen, E. W., Thomassen, J. Q., & Frikke‐Schmidt, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159063 · Cited by 70
FACCHINI, F., Hollenbeck, C. B., Chen, Y. D. I., Chen, Y. I., & Reaven, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00582.x · Cited by 67
Aoyama, T., Yui, Y., Morishita, H., & Kawai, C. (1990) · Circulation · doi:10.1161/01.cir.81.6.1784 · Cited by 67
Metabolism of human apolipoproteins A-I and A-II: compartmental models
Zech, L. A., Schaefer, E. J., Bronzert, T. J., AAMODT, R. L., & Brewer, H. B. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38025-1 · Cited by 67
Serum lipoprotiens in four European communities: a quantitative comparison
Lewis, B., Chait, A., Sigurdsson, G. T., Mancini, M., Farinaro, E., Oriente, P., Carlson, L. A., ERICSSON, M., Micheli, H., & Pometta, D. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00830.x · Cited by 67
Glück, Z., Weidmann, P. U., Mordasini, R., Bachmann, C., Riesen, W., Peheim, E., Keusch, G., & Meier, A. (1980) · Metabolism · doi:10.1016/0026-0495(80)90065-7 · Cited by 67
Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.2.2.114 · Cited by 67
Mahaney, M. C., Blangero, J., Rainwater, D. L., Comuzzie, A. G., VandeBerg, J. L., D, M. P. S. M., MacCluer, J. W., & Hixson, J. E. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1730 · Cited by 67
Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County.
Tyroler, H. A., HEISS, G. M., Schonfeld, G., Cooper, G. R., Heyden, S., & Hames, C. G. (1980) · Circulation · doi:10.1161/01.cir.62.2.249 · Cited by 67
Rethinking good cholesterol: a clinicians' guide to understanding HDL
Xiang, A. S., & Kingwell, B. A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30003-8 · Cited by 70
Grass, D., Saini, U., Felkner, R. H., Wallace, R., Lago, W., Young, S. G., & Swanson, M. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39866-7 · Cited by 66
Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol
Lin, G., & Oram, J. F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00503-1 · Cited by 66
Very low high-density lipoproteins without coronary atherosclerosis
Rader, D. J., Ikewaki, K., Duverger, N., Feuerstein, I. M., Brewer, H. B., & CONNOR, W. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92933-k · Cited by 66
Lipid Metabolism in Non-Insulin-Dependent Diabetes Mellitus
Greenfield, M. S. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.8.1498 · Cited by 66
Zimmerman, J., KAUFMANN, N. A., FAINARU, M., Eisenberg, S., Oschry, Y., Friedlander, Y., & Stein, Y. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.2.115 · Cited by 66
Glueck, C. J., Gartside, P. S., Laskarzewski, P. M., Khoury, P. R., & Tyroler, H. A. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90677-x · Cited by 66
Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
Pasotti, C., Capra, A., Fiorella, G., Vibelli, C., & Chierichetti, S. M. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01953.x · Cited by 66
Chang, L. B. F., Hopkins, G. J., & Barter, P. J. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90084-x · Cited by 66
Alphalipoprotein cholesterol levels in relation to acute myocardial infarction and its risk factors
Wiklund, O., Fager, G., Craig, I. H., Wilhelmsson, C., VEDIN, A., Olofsson, S. ‐., Bondjers, G., & Wilhelmsen, L. (1980) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518009095573 · Cited by 66
Lipids and diabetic retinopathy
Lim, L. S., & Wong, T. Y. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.641531 · Cited by 67
Morishima, A., Ohkubo, N., Maeda, N., Miki, T., & Mitsuda, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306336200 · Cited by 65
Metadata
- Authors
- Miller, G. J., & Miller, N. E.
- Affiliations
- University Hospital Llandough (GB)
- Edinburgh Royal Infirmary (GB)
- ORCID
- Miller, G.J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1975-01
- Volume
- 305
- Issue
- 7897
- Pages
- 16-19
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994967652
- Cited by
- 2,621
- References
- 59
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
- FWCI
- 157.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
- MeSH terms
- Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review